 | • レポートコード：GIR-107A14805 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、子宮筋腫塞栓術のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。子宮筋腫塞栓術の種類別市場規模（ゼラチンスポンジ、ポリビニルアルコール（PVA）粒子、トリサクリルゼラチンミクロスフェア（TAGM）、ポリメチルメタクリレート（PMMA）ミクロスフェア、その他）、用途別市場規模（臨床研究所、病院、手術センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・子宮筋腫塞栓術の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Astellas Pharma、Nippon Kayaku、Pfizer、Boston Scientific Corporation、Merit Medical Systems、Cook Medical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ゼラチンスポンジ、ポリビニルアルコール（PVA）粒子、トリサクリルゼラチンミクロスフェア（TAGM）、ポリメチルメタクリレート（PMMA）ミクロスフェア、その他 ・用途別分析2016年-2026年：臨床研究所、病院、手術センター、その他 ・子宮筋腫塞栓術の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・子宮筋腫塞栓術のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・子宮筋腫塞栓術のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・子宮筋腫塞栓術の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・子宮筋腫塞栓術の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Uterine Fibroid Embolization Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Uterine Fibroid Embolization Agents size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Uterine Fibroid Embolization Agents market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Uterine Fibroid Embolization Agents market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Gelatin Sponge
Polyvinyl Alcohol (PVA) Particles
Trisacryl Gelatin Microspheres (TAGM)
Polymethyl Methacrylate (PMMA) Microspheres
Others
Market segment by Application can be divided into
Clinical Research Institutes
Hospital
Surgical Centers
Others
The key market players for global Uterine Fibroid Embolization Agents market are listed below:
Astellas Pharma
Nippon Kayaku
Pfizer
Boston Scientific Corporation
Merit Medical Systems
Cook Medical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Uterine Fibroid Embolization Agents product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Uterine Fibroid Embolization Agents, with price, sales, revenue and global market share of Uterine Fibroid Embolization Agents from 2019 to 2021.
Chapter 3, the Uterine Fibroid Embolization Agents competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Uterine Fibroid Embolization Agents breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Uterine Fibroid Embolization Agents market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Uterine Fibroid Embolization Agents sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Uterine Fibroid Embolization Agents Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Uterine Fibroid Embolization Agents Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Gelatin Sponge
1.2.3 Polyvinyl Alcohol (PVA) Particles
1.2.4 Trisacryl Gelatin Microspheres (TAGM)
1.2.5 Polymethyl Methacrylate (PMMA) Microspheres
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Uterine Fibroid Embolization Agents Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Clinical Research Institutes
1.3.3 Hospital
1.3.4 Surgical Centers
1.3.5 Others
1.4 Global Uterine Fibroid Embolization Agents Market Size & Forecast
1.4.1 Global Uterine Fibroid Embolization Agents Sales in Value (2016-2026))
1.4.2 Global Uterine Fibroid Embolization Agents Sales in Volume (2016-2026)
1.4.3 Global Uterine Fibroid Embolization Agents Price by Type (2016-2026) & (USD/Unit)
1.5 Global Uterine Fibroid Embolization Agents Production Capacity Analysis
1.5.1 Global Uterine Fibroid Embolization Agents Total Production Capacity (2016-2026)
1.5.2 Global Uterine Fibroid Embolization Agents Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Uterine Fibroid Embolization Agents Market Drivers
1.6.2 Uterine Fibroid Embolization Agents Market Restraints
1.6.3 Uterine Fibroid Embolization Agents Trends Analysis
2 Manufacturers Profiles
2.1 Astellas Pharma
2.1.1 Astellas Pharma Details
2.1.2 Astellas Pharma Major Business
2.1.3 Astellas Pharma Uterine Fibroid Embolization Agents Product and Services
2.1.4 Astellas Pharma Uterine Fibroid Embolization Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Nippon Kayaku
2.2.1 Nippon Kayaku Details
2.2.2 Nippon Kayaku Major Business
2.2.3 Nippon Kayaku Uterine Fibroid Embolization Agents Product and Services
2.2.4 Nippon Kayaku Uterine Fibroid Embolization Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Uterine Fibroid Embolization Agents Product and Services
2.3.4 Pfizer Uterine Fibroid Embolization Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Boston Scientific Corporation
2.4.1 Boston Scientific Corporation Details
2.4.2 Boston Scientific Corporation Major Business
2.4.3 Boston Scientific Corporation Uterine Fibroid Embolization Agents Product and Services
2.4.4 Boston Scientific Corporation Uterine Fibroid Embolization Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Merit Medical Systems
2.5.1 Merit Medical Systems Details
2.5.2 Merit Medical Systems Major Business
2.5.3 Merit Medical Systems Uterine Fibroid Embolization Agents Product and Services
2.5.4 Merit Medical Systems Uterine Fibroid Embolization Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Cook Medical
2.6.1 Cook Medical Details
2.6.2 Cook Medical Major Business
2.6.3 Cook Medical Uterine Fibroid Embolization Agents Product and Services
2.6.4 Cook Medical Uterine Fibroid Embolization Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Uterine Fibroid Embolization Agents Sales by Manufacturer
3.1 Global Uterine Fibroid Embolization Agents Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Uterine Fibroid Embolization Agents Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Uterine Fibroid Embolization Agents
3.4 Market Concentration Rate
3.4.1 Top 3 Uterine Fibroid Embolization Agents Manufacturer Market Share
3.4.2 Top 6 Uterine Fibroid Embolization Agents Manufacturer Market Share
3.5 Global Uterine Fibroid Embolization Agents Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Uterine Fibroid Embolization Agents Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Uterine Fibroid Embolization Agents Market Size by Region
4.1.1 Global Uterine Fibroid Embolization Agents Sales in Volume by Region (2016-2026)
4.1.2 Global Uterine Fibroid Embolization Agents Revenue by Region (2016-2026)
4.2 North America Uterine Fibroid Embolization Agents Revenue (2016-2026)
4.3 Europe Uterine Fibroid Embolization Agents Revenue (2016-2026)
4.4 Asia-Pacific Uterine Fibroid Embolization Agents Revenue (2016-2026)
4.5 South America Uterine Fibroid Embolization Agents Revenue (2016-2026)
4.6 Middle East and Africa Uterine Fibroid Embolization Agents Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Uterine Fibroid Embolization Agents Sales in Volume by Type (2016-2026)
5.2 Global Uterine Fibroid Embolization Agents Revenue by Type (2016-2026)
5.3 Global Uterine Fibroid Embolization Agents Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Uterine Fibroid Embolization Agents Sales in Volume by Application (2016-2026)
6.2 Global Uterine Fibroid Embolization Agents Revenue by Application (2016-2026)
6.3 Global Uterine Fibroid Embolization Agents Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Uterine Fibroid Embolization Agents Sales by Type (2016-2026)
7.2 North America Uterine Fibroid Embolization Agents Sales by Application (2016-2026)
7.3 North America Uterine Fibroid Embolization Agents Market Size by Country
7.3.1 North America Uterine Fibroid Embolization Agents Sales in Volume by Country (2016-2026)
7.3.2 North America Uterine Fibroid Embolization Agents Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Uterine Fibroid Embolization Agents Sales by Type (2016-2026)
8.2 Europe Uterine Fibroid Embolization Agents Sales by Application (2016-2026)
8.3 Europe Uterine Fibroid Embolization Agents Market Size by Country
8.3.1 Europe Uterine Fibroid Embolization Agents Sales in Volume by Country (2016-2026)
8.3.2 Europe Uterine Fibroid Embolization Agents Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Uterine Fibroid Embolization Agents Sales by Type (2016-2026)
9.2 Asia-Pacific Uterine Fibroid Embolization Agents Sales by Application (2016-2026)
9.3 Asia-Pacific Uterine Fibroid Embolization Agents Market Size by Region
9.3.1 Asia-Pacific Uterine Fibroid Embolization Agents Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Uterine Fibroid Embolization Agents Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Uterine Fibroid Embolization Agents Sales by Type (2016-2026)
10.2 South America Uterine Fibroid Embolization Agents Sales by Application (2016-2026)
10.3 South America Uterine Fibroid Embolization Agents Market Size by Country
10.3.1 South America Uterine Fibroid Embolization Agents Sales in Volume by Country (2016-2026)
10.3.2 South America Uterine Fibroid Embolization Agents Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Uterine Fibroid Embolization Agents Sales by Type (2016-2026)
11.2 Middle East & Africa Uterine Fibroid Embolization Agents Sales by Application (2016-2026)
11.3 Middle East & Africa Uterine Fibroid Embolization Agents Market Size by Country
11.3.1 Middle East & Africa Uterine Fibroid Embolization Agents Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Uterine Fibroid Embolization Agents Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Uterine Fibroid Embolization Agents Typical Distributors
12.3 Uterine Fibroid Embolization Agents Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Uterine Fibroid Embolization Agents Revenue by Type, (USD Million), 2021-2026
Table 2. Global Uterine Fibroid Embolization Agents Revenue by Application, (USD Million), 2021-2026
Table 3. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Astellas Pharma Major Business
Table 5. Astellas Pharma Uterine Fibroid Embolization Agents Product and Services
Table 6. Astellas Pharma Uterine Fibroid Embolization Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Nippon Kayaku Basic Information, Manufacturing Base and Competitors
Table 8. Nippon Kayaku Major Business
Table 9. Nippon Kayaku Uterine Fibroid Embolization Agents Product and Services
Table 10. Nippon Kayaku Uterine Fibroid Embolization Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Uterine Fibroid Embolization Agents Product and Services
Table 14. Pfizer Uterine Fibroid Embolization Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 16. Boston Scientific Corporation Major Business
Table 17. Boston Scientific Corporation Uterine Fibroid Embolization Agents Product and Services
Table 18. Boston Scientific Corporation Uterine Fibroid Embolization Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Merit Medical Systems Basic Information, Manufacturing Base and Competitors
Table 20. Merit Medical Systems Major Business
Table 21. Merit Medical Systems Uterine Fibroid Embolization Agents Product and Services
Table 22. Merit Medical Systems Uterine Fibroid Embolization Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Cook Medical Basic Information, Manufacturing Base and Competitors
Table 24. Cook Medical Major Business
Table 25. Cook Medical Uterine Fibroid Embolization Agents Product and Services
Table 26. Cook Medical Uterine Fibroid Embolization Agents Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Global Uterine Fibroid Embolization Agents Sales by Manufacturer (2019-2021e) & (K Units)
Table 28. Global Uterine Fibroid Embolization Agents Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 29. Market Position of Manufacturers in Uterine Fibroid Embolization Agents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 30. Global Uterine Fibroid Embolization Agents Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Uterine Fibroid Embolization Agents Production Site of Key Manufacturer
Table 32. Uterine Fibroid Embolization Agents New Entrant and Capacity Expansion Plans
Table 33. Uterine Fibroid Embolization Agents Mergers & Acquisitions in the Past Five Years
Table 34. Global Uterine Fibroid Embolization Agents Sales by Region (2016-2021e) & (K Units)
Table 35. Global Uterine Fibroid Embolization Agents Sales by Region (2021-2026) & (K Units)
Table 36. Global Uterine Fibroid Embolization Agents Revenue by Region (2016-2021e) & (USD Million)
Table 37. Global Uterine Fibroid Embolization Agents Revenue by Region (2021-2026) & (USD Million)
Table 38. Global Uterine Fibroid Embolization Agents Sales by Type (2016-2021e) & (K Units)
Table 39. Global Uterine Fibroid Embolization Agents Sales by Type (2021-2026) & (K Units)
Table 40. Global Uterine Fibroid Embolization Agents Revenue by Type (2016-2021e) & (USD Million)
Table 41. Global Uterine Fibroid Embolization Agents Revenue by Type (2021-2026) & (USD Million)
Table 42. Global Uterine Fibroid Embolization Agents Price by Type (2016-2021e) & (USD/Unit)
Table 43. Global Uterine Fibroid Embolization Agents Price by Type (2021-2026) & (USD/Unit)
Table 44. Global Uterine Fibroid Embolization Agents Sales by Application (2016-2021e) & (K Units)
Table 45. Global Uterine Fibroid Embolization Agents Sales by Application (2021-2026) & (K Units)
Table 46. Global Uterine Fibroid Embolization Agents Revenue by Application (2016-2021e) & (USD Million)
Table 47. Global Uterine Fibroid Embolization Agents Revenue by Application (2021-2026) & (USD Million)
Table 48. Global Uterine Fibroid Embolization Agents Price by Application (2016-2021e) & (USD/Unit)
Table 49. Global Uterine Fibroid Embolization Agents Price by Application (2021-2026) & (USD/Unit)
Table 50. North America Uterine Fibroid Embolization Agents Sales by Country (2016-2021e) & (K Units)
Table 51. North America Uterine Fibroid Embolization Agents Sales by Country (2021-2026) & (K Units)
Table 52. North America Uterine Fibroid Embolization Agents Revenue by Country (2016-2021e) & (USD Million)
Table 53. North America Uterine Fibroid Embolization Agents Revenue by Country (2021-2026) & (USD Million)
Table 54. North America Uterine Fibroid Embolization Agents Sales by Type (2016-2021e) & (K Units)
Table 55. North America Uterine Fibroid Embolization Agents Sales by Type (2021-2026) & (K Units)
Table 56. North America Uterine Fibroid Embolization Agents Sales by Application (2016-2021e) & (K Units)
Table 57. North America Uterine Fibroid Embolization Agents Sales by Application (2021-2026) & (K Units)
Table 58. Europe Uterine Fibroid Embolization Agents Sales by Country (2016-2021e) & (K Units)
Table 59. Europe Uterine Fibroid Embolization Agents Sales by Country (2021-2026) & (K Units)
Table 60. Europe Uterine Fibroid Embolization Agents Revenue by Country (2016-2021e) & (USD Million)
Table 61. Europe Uterine Fibroid Embolization Agents Revenue by Country (2021-2026) & (USD Million)
Table 62. Europe Uterine Fibroid Embolization Agents Sales by Type (2016-2021e) & (K Units)
Table 63. Europe Uterine Fibroid Embolization Agents Sales by Type (2021-2026) & (K Units)
Table 64. Europe Uterine Fibroid Embolization Agents Sales by Application (2016-2021e) & (K Units)
Table 65. Europe Uterine Fibroid Embolization Agents Sales by Application (2021-2026) & (K Units)
Table 66. Asia-Pacific Uterine Fibroid Embolization Agents Sales by Region (2016-2021e) & (K Units)
Table 67. Asia-Pacific Uterine Fibroid Embolization Agents Sales by Region (2021-2026) & (K Units)
Table 68. Asia-Pacific Uterine Fibroid Embolization Agents Revenue by Region (2016-2021e) & (USD Million)
Table 69. Asia-Pacific Uterine Fibroid Embolization Agents Revenue by Region (2021-2026) & (USD Million)
Table 70. Asia-Pacific Uterine Fibroid Embolization Agents Sales by Type (2016-2021e) & (K Units)
Table 71. Asia-Pacific Uterine Fibroid Embolization Agents Sales by Type (2021-2026) & (K Units)
Table 72. Asia-Pacific Uterine Fibroid Embolization Agents Sales by Application (2016-2021e) & (K Units)
Table 73. Asia-Pacific Uterine Fibroid Embolization Agents Sales by Application (2021-2026) & (K Units)
Table 74. South America Uterine Fibroid Embolization Agents Sales by Country (2016-2021e) & (K Units)
Table 75. South America Uterine Fibroid Embolization Agents Sales by Country (2021-2026) & (K Units)
Table 76. South America Uterine Fibroid Embolization Agents Revenue by Country (2016-2021e) & (USD Million)
Table 77. South America Uterine Fibroid Embolization Agents Revenue by Country (2021-2026) & (USD Million)
Table 78. South America Uterine Fibroid Embolization Agents Sales by Type (2016-2021e) & (K Units)
Table 79. South America Uterine Fibroid Embolization Agents Sales by Type (2021-2026) & (K Units)
Table 80. South America Uterine Fibroid Embolization Agents Sales by Application (2016-2021e) & (K Units)
Table 81. South America Uterine Fibroid Embolization Agents Sales by Application (2021-2026) & (K Units)
Table 82. Middle East & Africa Uterine Fibroid Embolization Agents Sales by Country (2016-2021e) & (K Units)
Table 83. Middle East & Africa Uterine Fibroid Embolization Agents Sales by Country (2021-2026) & (K Units)
Table 84. Middle East & Africa Uterine Fibroid Embolization Agents Revenue by Country (2016-2021e) & (USD Million)
Table 85. Middle East & Africa Uterine Fibroid Embolization Agents Revenue by Country (2021-2026) & (USD Million)
Table 86. Middle East & Africa Uterine Fibroid Embolization Agents Sales by Type (2016-2021e) & (K Units)
Table 87. Middle East & Africa Uterine Fibroid Embolization Agents Sales by Type (2021-2026) & (K Units)
Table 88. Middle East & Africa Uterine Fibroid Embolization Agents Sales by Application (2016-2021e) & (K Units)
Table 89. Middle East & Africa Uterine Fibroid Embolization Agents Sales by Application (2021-2026) & (K Units)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Uterine Fibroid Embolization Agents Typical Distributors
Table 93. Uterine Fibroid Embolization Agents Typical Customers
List of Figures
Figure 1. Uterine Fibroid Embolization Agents Picture
Figure 2. Global Uterine Fibroid Embolization Agents Sales Market Share by Type in 2020
Figure 3. Gelatin Sponge
Figure 4. Polyvinyl Alcohol (PVA) Particles
Figure 5. Trisacryl Gelatin Microspheres (TAGM)
Figure 6. Polymethyl Methacrylate (PMMA) Microspheres
Figure 7. Others
Figure 8. Global Uterine Fibroid Embolization Agents Sales Market Share by Application in 2020
Figure 9. Clinical Research Institutes
Figure 10. Hospital
Figure 11. Surgical Centers
Figure 12. Others
Figure 13. Global Uterine Fibroid Embolization Agents Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 14. Global Uterine Fibroid Embolization Agents Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Uterine Fibroid Embolization Agents Sales (2016-2026) & (K Units)
Figure 16. Global Uterine Fibroid Embolization Agents Price by Type (2016-2026) & (USD/Unit)
Figure 17. Global Uterine Fibroid Embolization Agents Production Capacity (2016-2026) & (K Units)
Figure 18. Global Uterine Fibroid Embolization Agents Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Uterine Fibroid Embolization Agents Market Drivers
Figure 20. Uterine Fibroid Embolization Agents Market Restraints
Figure 21. Uterine Fibroid Embolization Agents Market Trends
Figure 22. Global Uterine Fibroid Embolization Agents Sales Market Share by Manufacturer in 2020
Figure 23. Global Uterine Fibroid Embolization Agents Revenue Market Share by Manufacturer in 2020
Figure 24. Uterine Fibroid Embolization Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Uterine Fibroid Embolization Agents Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Uterine Fibroid Embolization Agents Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Uterine Fibroid Embolization Agents Sales Market Share by Region (2016-2026)
Figure 28. Global Uterine Fibroid Embolization Agents Revenue Market Share by Region (2016-2026)
Figure 29. North America Uterine Fibroid Embolization Agents Revenue (2016-2026) & (USD Million)
Figure 30. Europe Uterine Fibroid Embolization Agents Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Uterine Fibroid Embolization Agents Revenue (2016-2026) & (USD Million)
Figure 32. South America Uterine Fibroid Embolization Agents Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Uterine Fibroid Embolization Agents Revenue (2016-2026) & (USD Million)
Figure 34. Global Uterine Fibroid Embolization Agents Sales Market Share by Type (2016-2026)
Figure 35. Global Uterine Fibroid Embolization Agents Revenue Market Share by Type (2016-2026)
Figure 36. Global Uterine Fibroid Embolization Agents Price by Type (2016-2026) & (USD/Unit)
Figure 37. Global Uterine Fibroid Embolization Agents Sales Market Share by Application (2016-2026)
Figure 38. Global Uterine Fibroid Embolization Agents Revenue Market Share by Application (2016-2026)
Figure 39. Global Uterine Fibroid Embolization Agents Price by Application (2016-2026) & (USD/Unit)
Figure 40. North America Uterine Fibroid Embolization Agents Sales Market Share by Type (2016-2026)
Figure 41. North America Uterine Fibroid Embolization Agents Sales Market Share by Application (2016-2026)
Figure 42. North America Uterine Fibroid Embolization Agents Sales Market Share by Country (2016-2026)
Figure 43. North America Uterine Fibroid Embolization Agents Revenue Market Share by Country (2016-2026)
Figure 44. United States Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Uterine Fibroid Embolization Agents Sales Market Share by Type (2016-2026)
Figure 48. Europe Uterine Fibroid Embolization Agents Sales Market Share by Application (2016-2026)
Figure 49. Europe Uterine Fibroid Embolization Agents Sales Market Share by Country (2016-2026)
Figure 50. Europe Uterine Fibroid Embolization Agents Revenue Market Share by Country (2016-2026)
Figure 51. Germany Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Uterine Fibroid Embolization Agents Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Uterine Fibroid Embolization Agents Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Uterine Fibroid Embolization Agents Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Uterine Fibroid Embolization Agents Revenue Market Share by Region (2016-2026)
Figure 60. China Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Uterine Fibroid Embolization Agents Sales Market Share by Type (2016-2026)
Figure 67. South America Uterine Fibroid Embolization Agents Sales Market Share by Application (2016-2026)
Figure 68. South America Uterine Fibroid Embolization Agents Sales Market Share by Country (2016-2026)
Figure 69. South America Uterine Fibroid Embolization Agents Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Uterine Fibroid Embolization Agents Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Uterine Fibroid Embolization Agents Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Uterine Fibroid Embolization Agents Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Uterine Fibroid Embolization Agents Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Uterine Fibroid Embolization Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界のポリメチルメタクリレート（PMMA）ミクロスフェア市場 2021：企業別、地域別、種類・用途別 The Polymethyl Methacrylate (PMMA) Microspheres market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…- 世界の塞栓ミクロスフェア市場 2021：企業別、地域別、種類・用途別 The Embolization Microsphere market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の前立腺動脈塞栓術市場 2021：企業別、地域別、種類・用途別 The Prostatic Artery Embolization market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の子宮がん治療・診断市場 2021：企業別、地域別、種類・用途別 The Uterine Cancer Therapies and Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 世界の神経血管塞栓装置市場 2021：企業別、地域別、種類・用途別 The Neurovascular Embolization Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…